跳转至内容
Merck
CN

128775

4-羟基哌啶

98%

别名:

4-哌啶醇

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
C5H11NO
化学文摘社编号:
分子量:
101.15
UNSPSC Code:
12352100
NACRES:
NA.22
PubChem Substance ID:
EC Number:
226-373-1
Beilstein/REAXYS Number:
102738
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

4-羟基哌啶, 98%

InChI key

HDOWRFHMPULYOA-UHFFFAOYSA-N

InChI

1S/C5H11NO/c7-5-1-3-6-4-2-5/h5-7H,1-4H2

SMILES string

OC1CCNCC1

assay

98%

bp

108-114 °C/10 mmHg (lit.)

functional group

hydroxyl

Quality Level

正在寻找类似产品? 访问 产品对比指南

Application

4-羟基哌啶(4-哌啶醇)可用于合成高效、高选择性的IP(PGI(2) 受体)激动剂。它也可用于研究铜催化的N-芳基化和O-芳基化作用。

General description

研究了4-羟基哌啶的分子结构、振动光谱、NBO和紫外光谱分析。已经发现具有取代的4-哌啶醇核心的化合物是人H(3)受体的有效拮抗剂

pictograms

Exclamation mark

signalword

Warning

hcodes

Hazard Classifications

Eye Irrit. 2 - Skin Irrit. 2

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

dust mask type N95 (US), Eyeshields, Gloves


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

S Sebastian et al.
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 75(3), 941-952 (2010-01-09)
In this work, we report a combined experimental and theoretical study on molecular structure, vibrational spectra, NBO and UV-spectral analysis of 4-Hydroxypiperidine (4-HP). The FT-IR solid phase (4000-400 cm(-1)), FT-IR gas phase (5000-400 cm(-1)) and FT-Raman spectra (3500-50 cm(-1)) of
N- versus O-arylation of aminoalcohols: orthogonal selectivity in copper-based catalysts.
Alexandr Shafir et al.
Journal of the American Chemical Society, 129(12), 3490-3491 (2007-03-08)
James T Anderson et al.
Bioorganic & medicinal chemistry letters, 20(21), 6246-6249 (2010-09-14)
Compounds containing a substituted 4-piperidinol core have been found to be potent antagonists of the human H(3) receptor. The compounds exhibited up to a 60-fold preference for inhibiting the human H(3) receptor over the mouse and showed a low binding
Yasuhiro Morita et al.
Molecules (Basel, Switzerland), 17(2), 1233-1246 (2012-02-02)
An efficient synthesis of a highly potent and selective IP (PGI(2) receptor) agonist that is not structurally analogous to PGI(2) is described. This synthesis is accomplished through the following key steps: Nucleophilic ring-opening of 3-(4-chlorophenyl)-oxazolidin-2-one prepared by a one-pot procedure

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持